A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Hepatitis b · Anti-PD-1 Antibody · Peg-IFNα

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The 2nd affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Contact: Study coordinator (HONG REN) · renhong0531@vip.sina.com · +8613983888786
Contact: Study coordinator (Dachuan Cai) · cqmucdc@cqmu.edu.cn · +8618323409779
Contact: Principal Investigator (HONG REN)

Study leads

Hong Ren, MM
Study Director
The Second Affiliated Hospital of Chongqing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)

Chronic Hepatitis B Virus (HBV) Infection

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B Virus Infection

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE2

Jilin City, China

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

Chronic Hepatitis B-related Liver Fibrosis

Abroad (travel likely)RecruitingPHASE2

Chongqing, China